πŸ‡ΊπŸ‡Έ FDA
Patent

US 11560381

Compounds and uses thereof

granted A61PA61P35/00

Quick answer

US patent 11560381 (Compounds and uses thereof) held by FOGHORN THERAPEUTICS INC. expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FOGHORN THERAPEUTICS INC.
Grant date
Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P35/00